Stealth Company

AlphaRose Therapeutics

AlphaRose Therapeutics is building a new model for rare-disease drug development, bringing personalized genetic medicines to children that traditional pharma overlooks. Founded by entrepreneur and musician Casey McPherson after his daughter Rose's diagnosis, it combines antisense oligonucleotide (ASO) technology, AI-driven discovery, and a novel commercialization strategy to slash the cost and timeline of treating ultra-rare disease.